Target intelligence / Profile preview

Class II and IV histone deacetylases (Class II/IV HDACs)

Target
Class II/IV HDACs
Molecular classification
Enzyme, Histone modification, Transcription factor, Zinc-dependent deacetylase
01

Overview

Class II and IV histone deacetylases (HDACs) are a subset of the zinc-dependent classical HDAC family, comprising isoforms HDAC4, 5, 7, and 9 (Class IIa), HDAC6 and 10 (Class IIb), and HDAC11 (Class IV) [1, 2]. Unlike Class I HDACs, which are primarily nuclear and ubiquitously expressed, Class II and IV enzymes exhibit tissue-specific expression and frequently shuttle between the nucleus and cytoplasm to deacetylate both histones and non-histone proteins, such as alpha-tubulin and Hsp90 [1, 3]. These enzymes play critical roles in diverse physiological processes, including muscle differentiation, cardiac development, and the regulation of immune cell signaling, notably through the HDAC11-mediated repression of the anti-inflammatory cytokine IL-10 [3, 4]. In pathological contexts, Class II and IV HDACs are often dysregulated, contributing to the progression of various cancers, neurodegenerative disorders like Parkinson's disease, and chronic inflammatory conditions [1, 5]. Therapeutic targeting of these classes involves both pan-HDAC inhibitors and isoform-selective agents, such as ricolinostat (HDAC6-selective), which aim to leverage their specific roles in disease while minimizing systemic toxicities like thrombocytopenia and cardiotoxicity [4, 6]. Sources: [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433950/ [2] https://www.uniprot.org/ [3] https://pubmed.ncbi.nlm.nih.gov/22449854/ [4] https://www.ncbi.nlm.nih.gov/books/NBK560560/ [5] https://www.nature.com/articles/nrd1975 [6] https://www.fda.gov/drugs/information-on-drugs/approved-drugs

Other names
Class II and IV Histone DeacetylasesZn2+-dependent HDACs (Classes II and IV)Hda1-like and Hos3-like HDACsHDAC4, HDAC5, HDAC6, HDAC7, HDAC9, HDAC10, and HDAC11
02

Mechanism of action

Inhibition of the zinc-dependent catalytic site of Class II and IV histone deacetylases, preventing the removal of acetyl groups from lysine residues on histones and non-histone proteins. This leads to hyperacetylation, which alters chromatin structure to promote gene transcription (e.g., p21) or modulates the function of cytoplasmic proteins (e.g., tubulin, Hsp90), ultimately inducing cell cycle arrest, apoptosis, and anti-inflammatory effects [1, 4, 5].

03

Biological functions

Gene expression regulationChromatin remodelingProtein deacetylationNucleocytoplasmic shuttlingImmune response modulationCell differentiationAutophagy regulation
04

Disease associations

CancerNeurodegenerative diseaseInflammationCardiovascular diseaseMetabolic disorder
05

Safety considerations

ThrombocytopeniaNeutropeniaGastrointestinal toxicity (diarrhea, nausea)FatigueQT prolongation (cardiotoxicity)
06

Interacting drugs

Vorinostat

7 more in the full profile.

07

Biomarkers

Acetylated Histone H3Acetylated Histone H4Acetylated alpha-tubulinp21 (WAF1/CIP1) expression levels

Beyond the preview

Go deeper on Class II and IV histone deacetylases (Class II/IV HDACs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class II and IV histone deacetylases (Class II/IV HDACs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call